SeaStar Medical Holding (ICU) Treasury Shares (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Treasury Shares came in at $163632.0 in Q1 2026, down 22.85% YoY from $212083.0 in Q1 2025, and up 532.52% on a QoQ basis from $25870.0 in Q4 2025.
SeaStar Medical Holding (ICU) Treasury Shares (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of Treasury Shares data on file, last reported at $163632.0 in Q1 2026.
- Quarterly Treasury Shares fell 22.85% year-over-year to $163632.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $163632.0 (down 22.85% YoY) and the FY2025 annual result came in at $25870.0, up 17.86% from the prior year.
- Treasury Shares climbed to $163632.0 in Q1 2026, from $25870.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $10.4 million in Q1 2022 to a low of $3698.0 in Q4 2023.
- A 5-year average of $2.3 million and a median of $223051.0 in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares sank 98.76% — and 2025, when it soared 742.64%.
- Tracing ICU's Treasury Shares over 5 years: stood at $298389.0 in 2022, then slumped by 98.76% to $3698.0 in 2023, then jumped by 493.56% to $21950.0 in 2024, then climbed by 17.86% to $25870.0 in 2025, then jumped by 532.52% to $163632.0 in 2026.
- The last three Treasury Shares figures came in at $163632.0 (Q1 2026), $25870.0 (Q4 2025), and $263116.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 158,894.00 |
| Jun 30, 2026 | 158,894.00 |
| Mar 31, 2026 | 163,632.00 |
| Mar 31, 2026 | 163,632.00 |
| Dec 31, 2025 | 25,870.00 |
| Dec 31, 2025 | 25,870.00 |
| Sep 30, 2025 | 263,116.00 |
| Sep 30, 2025 | 263,116.00 |
| Jun 30, 2025 | 320,205.00 |
| Jun 30, 2025 | 320,205.00 |
| Mar 31, 2025 | 212,083.00 |
| Mar 31, 2025 | 212,083.00 |
| Dec 31, 2024 | 21,950.00 |
| Dec 31, 2024 | 21,950.00 |
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Mar 31, 2024 | 234,019.00 |
| Mar 31, 2024 | 234,019.00 |